|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | |
| A61K 39/395 | |||
| A61P 3/06 |
| (11) | Number of the document | 2205639 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08841231.7 |
| Date of filing the European patent application | 2008-10-27 | |
| (97) | Date of publication of the European application | 2010-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2015-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/081311 |
| Date | 2008-10-27 |
| (87) | Number | WO 2009/055783 |
| Date | 2009-04-30 |
| (30) | Number | Date | Country code |
| 982922 P | 2007-10-26 | US |
| (72) |
HEDRICK, Joseph A., US
MONSMA, Frederick James, Jr., US
CHURAKOVA, Tatyana, US
HOLLENBAUGH, Diane, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTI-PCSK9 AND METHODS FOR TREATING LIPID AND CHOLESTEROL DISORDERS |
| ANTI-PCSK9 AND METHODS FOR TREATING LIPID AND CHOLESTEROL DISORDERS |